Family Medicine Doctors in Foster City, CA Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Dr. Ka Wai Tam, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 E Hillsdale Blvd, Suite 270, Foster City, CA 94404 Phone: 650-918-5080 Fax: 650-403-6000 |
 Dr. Megan L. Ancker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 E. Hillsdale Blvd., 2nd Floor, Foster City, CA 94404 Phone: 650-570-2299 Fax: 650-570-5949 |
Dr. Alicea Xiaoyan Wu, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 Lakeside Dr, Foster City, CA 94404 Phone: 650-574-3000 |
Dr. Dana Walter Ludwig, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 Dolphin Isle, Foster City, CA 94404 Phone: 650-303-0886 |
Dr. Steven Jeffrey Harris, M.D. Family Medicine - Hospice and Palliative Medicine Medicare: Not Enrolled in Medicare Practice Location: 1098 Foster City Blvd Ste 305, Foster City, CA 94404 Phone: 650-474-2130 Fax: 650-445-0912 |
Alexander Sable-smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 E Hillsdale Blvd Ste 200, Foster City, CA 94404 Phone: 650-667-2322 |
News Archive
Research finding could lead to first-ever target for drug therapy for lymphedema
A genetic mutation for inherited lymphedema associated with lymphatic function has been discovered that could help create new treatments for the condition, say researchers at the University of Pittsburgh Graduate School of Public Health. Their findings are reported in the June issue of the American Journal of Human Genetics.
Heat and gut microbiota promote stronger bones
Osteoporosis, a bone disease linked to ageing, is characterized by a loss of bone density, micro-architectural deterioration of the bones and an increased risk of fractures.
Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation
An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered.
FDA accepts Antares Pharma's New Drug Application for OTREXUP
Antares Pharma, Inc. today announced that the New Drug Application for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.
› Verified 2 days ago
Internal Medicine
Family Medicine
Pediatrics
Infectious Disease
Pathology
Ophthalmology
Anesthesiology
General Practice
Radiology
Preventive Medicine
Emergency Medicine